Unichem Laboratories Limited

NSEI:UNICHEMLAB Stock Report

Market Cap: ₹32.7b

Unichem Laboratories Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Unichem Laboratories.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth16.1%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Analysis Article • May 30

Impressive Earnings May Not Tell The Whole Story For Unichem Laboratories (NSE:UNICHEMLAB)

Unichem Laboratories Limited's ( NSE:UNICHEMLAB ) robust earnings report didn't manage to move the market for its...
Analysis Article • Aug 06

Here's Why Unichem Laboratories (NSE:UNICHEMLAB) Can Manage Its Debt Responsibly

NSEI:UNICHEMLAB 1 Year Share Price vs Fair Value Explore Unichem Laboratories's Fair Values from the Community and...
Analysis Article • Jul 12

Unichem Laboratories' (NSE:UNICHEMLAB) Promising Earnings May Rest On Soft Foundations

Despite posting some strong earnings, the market for Unichem Laboratories Limited's ( NSE:UNICHEMLAB ) stock hasn't...
Analysis Article • Jun 19

Potential Upside For Unichem Laboratories Limited (NSE:UNICHEMLAB) Not Without Risk

You may think that with a price-to-sales (or "P/S") ratio of 1.9x Unichem Laboratories Limited ( NSE:UNICHEMLAB ) is a...
Analysis Article • Feb 28

We Think Unichem Laboratories (NSE:UNICHEMLAB) Can Stay On Top Of Its Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Nov 02

Revenues Tell The Story For Unichem Laboratories Limited (NSE:UNICHEMLAB) As Its Stock Soars 26%

Unichem Laboratories Limited ( NSE:UNICHEMLAB ) shares have continued their recent momentum with a 26% gain in the last...
Analysis Article • Sep 13

It's A Story Of Risk Vs Reward With Unichem Laboratories Limited (NSE:UNICHEMLAB)

Unichem Laboratories Limited's ( NSE:UNICHEMLAB ) price-to-sales (or "P/S") ratio of 2.6x might make it look like a buy...
Analysis Article • Feb 06

Optimistic Investors Push Unichem Laboratories Limited (NSE:UNICHEMLAB) Shares Up 26% But Growth Is Lacking

Despite an already strong run, Unichem Laboratories Limited ( NSE:UNICHEMLAB ) shares have been powering on, with a...
Analysis Article • Feb 01

Is Unichem Laboratories (NSE:UNICHEMLAB) Using Debt Sensibly?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Analysis Article • Sep 06

Does Unichem Laboratories (NSE:UNICHEMLAB) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Jul 30

Unichem Laboratories (NSE:UNICHEMLAB) Is Due To Pay A Dividend Of ₹4.00

The board of Unichem Laboratories Limited ( NSE:UNICHEMLAB ) has announced that it will pay a dividend on the 20th of...
Analysis Article • Jul 23

There's Reason For Concern Over Unichem Laboratories Limited's (NSE:UNICHEMLAB) Massive 28% Price Jump

Unichem Laboratories Limited ( NSE:UNICHEMLAB ) shareholders would be excited to see that the share price has had a...
Analysis Article • Jul 15

Unichem Laboratories (NSE:UNICHEMLAB) Will Pay A Dividend Of ₹4.00

Unichem Laboratories Limited ( NSE:UNICHEMLAB ) has announced that it will pay a dividend of ₹4.00 per share on the...
Analysis Article • Jul 01

Unichem Laboratories (NSE:UNICHEMLAB) Will Pay A Dividend Of ₹4.00

Unichem Laboratories Limited ( NSE:UNICHEMLAB ) will pay a dividend of ₹4.00 on the 8th of September. Based on this...
Analysis Article • Nov 27

Unichem Laboratories (NSE:UNICHEMLAB) Is Making Moderate Use Of Debt

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Jun 05

Investors Shouldn't Be Too Comfortable With Unichem Laboratories' (NSE:UNICHEMLAB) Robust Earnings

Despite posting some strong earnings, the market for Unichem Laboratories Limited's ( NSE:UNICHEMLAB ) stock hasn't...
Analysis Article • Mar 02

Should Unichem Laboratories Limited (NSE:UNICHEMLAB) Be Part Of Your Income Portfolio?

Could Unichem Laboratories Limited ( NSE:UNICHEMLAB ) be an attractive dividend share to own for the long haul...
Analysis Article • Feb 09

Unichem Laboratories Limited's (NSE:UNICHEMLAB) Stock's Been Going Strong: Could Weak Financials Mean The Market Will Correct Its Share Price?

Most readers would already be aware that Unichem Laboratories' (NSE:UNICHEMLAB) stock increased significantly by 45...
Analysis Article • Jan 19

Should You Take Comfort From Insider Transactions At Unichem Laboratories Limited (NSE:UNICHEMLAB)?

It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be...
Analysis Article • Dec 29

Do Institutions Own Unichem Laboratories Limited (NSE:UNICHEMLAB) Shares?

If you want to know who really controls Unichem Laboratories Limited ( NSE:UNICHEMLAB ), then you'll have to look at...
Analysis Article • Dec 10

Is Unichem Laboratories (NSE:UNICHEMLAB) Weighed On By Its Debt Load?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Nov 23

Key Things To Understand About Unichem Laboratories' (NSE:UNICHEMLAB) CEO Pay Cheque

Prakash Mody has been the CEO of Unichem Laboratories Limited (NSE:UNICHEMLAB) since 2003, and this article will...
Analysis Article • Nov 02

Did Unichem Laboratories' (NSE:UNICHEMLAB) Share Price Deserve to Gain 41%?

The simplest way to invest in stocks is to buy exchange traded funds. But investors can boost returns by picking...
Analysis Article • Oct 13

Should You Buy Unichem Laboratories Limited (NSE:UNICHEMLAB) For Its 1.5% Dividend?

Could Unichem Laboratories Limited (NSE:UNICHEMLAB) be an attractive dividend share to own for the long haul...
Analysis Article • Sep 16

How Much Are Unichem Laboratories Limited (NSE:UNICHEMLAB) Insiders Spending On Buying Shares?

We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...
Analysis Article • Aug 26

Is Unichem Laboratories (NSE:UNICHEMLAB) Using Too Much Debt?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Aug 05

Is Unichem Laboratories Limited's (NSE:UNICHEMLAB) Shareholder Ownership Skewed Towards Insiders?

A look at the shareholders of Unichem Laboratories Limited (NSE:UNICHEMLAB) can tell us which group is most powerful...
Analysis Article • Jul 14

Would Shareholders Who Purchased Unichem Laboratories'(NSE:UNICHEMLAB) Stock Three Years Be Happy With The Share price Today?

While it may not be enough for some shareholders, we think it is good to see the Unichem Laboratories Limited...
Analysis Article • Jun 18

Zooming in on NSE:UNICHEMLAB's 2.4% Dividend Yield

Today we'll take a closer look at Unichem Laboratories Limited (NSE:UNICHEMLAB) from a dividend investor's...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Unichem Laboratories has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NSEI:UNICHEMLAB - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202622,0192,528-1,19436N/A
12/31/202522,1392,949N/AN/AN/A
9/30/202522,258885-1,049485N/A
6/30/202521,5421,250N/AN/AN/A
3/31/202521,1101,375-1,444-70N/A
12/31/202419,032-289N/AN/AN/A
9/30/202417,747-568491,391N/A
6/30/202417,281-606N/AN/AN/A
3/31/202417,851-938-85140N/A
12/31/202316,753146N/AN/AN/A
9/30/202315,434-1,333-2,499-2,239N/A
6/30/202314,566-1,795N/AN/AN/A
3/31/202313,430-2,022-1,294-851N/A
12/31/202213,109-865N/AN/AN/A
9/30/202213,197-367-1,112-163N/A
6/30/202212,815212N/AN/AN/A
3/31/202212,698331-3,866-2,596N/A
12/31/202111,740-388N/AN/AN/A
9/30/202111,890-12-2,877-1,131N/A
6/30/202112,158204N/AN/AN/A
3/31/202112,351343-2,548330N/A
12/31/202013,581175N/AN/AN/A
9/30/202013,067-206-3,819135N/A
6/30/202012,547-516N/AN/AN/A
3/31/202011,037-602-3,663198N/A
12/31/201912,653-113N/AN/AN/A
9/30/201912,71151N/A-1,307N/A
6/30/201912,366-113N/AN/AN/A
3/31/201911,800-256N/A-3,278N/A
12/31/201810,425-591N/AN/AN/A
3/31/20188,146-1,331N/A-1,123N/A
12/31/201715,855405N/AN/AN/A
3/31/20176,977-707N/A682N/A
3/31/201613,3271,081N/A1,117N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if UNICHEMLAB's forecast earnings growth is above the savings rate (6.9%).

Earnings vs Market: Insufficient data to determine if UNICHEMLAB's earnings are forecast to grow faster than the Indian market

High Growth Earnings: Insufficient data to determine if UNICHEMLAB's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if UNICHEMLAB's revenue is forecast to grow faster than the Indian market.

High Growth Revenue: Insufficient data to determine if UNICHEMLAB's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if UNICHEMLAB's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/06 21:09
End of Day Share Price 2026/07/06 00:00
Earnings2026/03/31
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Unichem Laboratories Limited is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rohit Bhat360 ONE Capital Market Private Limited
null nullAnand Rathi Shares and Stock Brokers Limited
Sriraam RathiAnand Rathi Shares and Stock Brokers Limited